SurModics Inc Asset Resilience Ratio
SurModics Inc asset resilience ratio. SurModics Inc (SRDX) has an Asset Resilience Ratio of 3.80% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can SurModics Inc fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of SurModics Inc (1999–2024)
Asset resilience ratio of SurModics Inc from 1999 to 2024. This chart shows how SurModics Inc's Asset Resilience Ratio has changed over time. Read SurModics Inc (SRDX) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down SurModics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SRDX current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $6.45 Million | 3.8% |
| Total Liquid Assets | $6.45 Million | 3.80% |
Asset Resilience Insights
- Limited Liquidity: SurModics Inc maintains only 3.80% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SurModics Inc Industry Peers by Asset Resilience Ratio
Compare SurModics Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
SurModics Inc Asset Resilience Ratio by Year (1999–2024)
SurModics Inc asset resilience ratio by year from 1999 to 2024. The table below shows the annual Asset Resilience Ratio data for SurModics Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-09-30 | 2.24% | $4.00 Million | $178.56 Million | +0.12pp |
| 2023-09-30 | 2.12% | $3.93 Million | $185.73 Million | -- |
| 2022-09-30 | 0.00% | $0.00 | $158.36 Million | -- |
| 2021-09-30 | 3.97% | $7.72 Million | $194.59 Million | -14.00pp |
| 2020-09-30 | 17.96% | $30.31 Million | $168.76 Million | +2.37pp |
| 2019-09-30 | 15.60% | $24.93 Million | $159.87 Million | -9.60pp |
| 2018-09-30 | 25.19% | $41.35 Million | $164.13 Million | +1.91pp |
| 2017-09-30 | 23.28% | $31.80 Million | $136.59 Million | +6.76pp |
| 2016-09-30 | 16.52% | $21.95 Million | $132.89 Million | -- |
| 2015-09-30 | 0.00% | $0.00 | $100.21 Million | -- |
| 2014-09-30 | 2.90% | $3.04 Million | $104.89 Million | -7.12pp |
| 2013-09-30 | 10.02% | $10.21 Million | $101.92 Million | -3.57pp |
| 2012-09-30 | 13.59% | $14.12 Million | $103.87 Million | +4.23pp |
| 2011-09-30 | 9.36% | $15.23 Million | $162.65 Million | +4.01pp |
| 2010-09-30 | 5.35% | $9.11 Million | $170.28 Million | +0.53pp |
| 2009-09-30 | 4.81% | $8.93 Million | $185.56 Million | -0.03pp |
| 2008-09-30 | 4.84% | $9.25 Million | $191.03 Million | -2.45pp |
| 2007-09-30 | 7.29% | $12.50 Million | $171.33 Million | -27.69pp |
| 2006-09-30 | 34.98% | $55.06 Million | $157.40 Million | +18.46pp |
| 2005-09-30 | 16.52% | $20.52 Million | $124.22 Million | +1.49pp |
| 2004-09-30 | 15.04% | $16.51 Million | $109.78 Million | +12.34pp |
| 2003-09-30 | 2.70% | $2.64 Million | $97.81 Million | -2.40pp |
| 2002-09-30 | 5.10% | $3.94 Million | $77.25 Million | -4.46pp |
| 2001-09-30 | 9.57% | $5.80 Million | $60.58 Million | -21.66pp |
| 2000-09-30 | 31.23% | $15.85 Million | $50.75 Million | +19.04pp |
| 1999-09-30 | 12.19% | $3.90 Million | $32.00 Million | -- |
About SurModics Inc
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision o… Read more